PDS Biotechnology Corp (PDSB): Cash & Equivalents
$26.71M
As of 2025-12-31
$5.60M
As of 2026-06-30
-28.7%
3-year compound annual growth
-1.5%
5-year compound annual growth
-14.6%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $26.71M | -35.9% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $41.69M | -26.3% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $56.56M | -23.4% | 2025-03-27, Balance as of period end |
| 2022-12-31 | $73.82M | +13.1% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $65.24M | +126.2% | 2023-03-28, Balance as of period end |
| 2020-12-31 | $28.84M | +137.1% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $12.16M | n/m | 2021-03-18, Balance as of period end |
| 2018-12-31 | $103.7K | -99.9% | 2020-03-27, Balance as of period end |
| 2017-12-31 | $88.07M | -17.2% | 2019-02-21, Balance as of period end |
| 2016-12-31 | $106.40M | -18.3% | 2018-03-01, Balance as of period end |
| 2015-12-31 | $130.19M | +848.3% | 2018-03-01, Balance as of period end |
| 2014-12-31 | $13.73M | +74.7% | 2017-03-02, Balance as of period end |
| 2013-12-31 | $7.86M | n/a | 2016-03-08, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | 2025-12-31 | $26.71M | -35.9% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $24.03M | +20.6% |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $345.1K | -44.9% |
| Sol-Gel Technologies Ltd. (SLGL) | 2025-12-31 | $11.03M | -43.4% |
| Veru Inc. (VERU) | 2025-09-30 | $15.79M | -36.6% |
| Talphera, Inc. (TLPH) | 2025-12-31 | $5.89M | -33.5% |
| Valion Bio, Inc. (VBIO) | 2025-12-31 | $12.64M | +531.6% |
| Nuvectis Pharma, Inc. (NVCT) | 2025-12-31 | $31.63M | +70.7% |
| Equillium, Inc. (EQ) | 2025-12-31 | $30.28M | +67.4% |
Compare PDSB, YARW, CPHI, SLGL side by side · Screen every company in Pharmaceutical Preparations ↗